Adhésion thérapeutique aux traitements oncologiques oraux et prise en charge interdisciplinaire [Therapeutic adherence to oral cancer therapy and interdisciplinary management].

Details

Serval ID
serval:BIB_059A43B298E4
Type
Article: article from journal or magazin.
Publication sub-type
Case report (case report): feedback on an observation with a short commentary.
Collection
Publications
Institution
Title
Adhésion thérapeutique aux traitements oncologiques oraux et prise en charge interdisciplinaire [Therapeutic adherence to oral cancer therapy and interdisciplinary management].
Journal
Revue Médicale Suisse
Author(s)
Jeanneret L.A., Schneider M.P., Troxler S., Bugnon O., Lüthi F.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
2011
Volume
7
Number
296
Pages
1154-8, 1160
Language
french
Notes
Publication types: Case Reports ; English Abstract ; Journal Article
Publication Status: ppublish
Abstract
Medication adherence is a well-known risk factor in internal medicine. However in oncology this dimension is emerging due to the increasing number of oral formulations. First results in the oral oncology literature suggest that patients' ability to cope with medical prescription decreases with time. This might preclude patients from reaching clinical outcomes. Factors impacting on medication adherence to oral oncology treatments have not been yet extensively described neither strategies to address them and support patient's needs. Oncologists and pharmacists in our University outpatient settings performed a pilot study which aimed at measuring and facilitating adherence to oral oncology treatments and at understanding determinants of patient's adherence. The ultimate purpose of such a patient-centered and interdisciplinary collaboration would be to promote patient self-management and complement the standard medical follow-up.
Keywords
Adenocarcinoma/drug therapy, Adenocarcinoma/secondary, Administration, Oral, Aged, Algorithms, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Cecal Neoplasms/drug therapy, Cecal Neoplasms/pathology, Deoxycytidine/administration & dosage, Deoxycytidine/analogs & derivatives, Female, Fluorouracil/administration & dosage, Fluorouracil/analogs & derivatives, Gastrointestinal Stromal Tumors/drug therapy, Humans, Interdisciplinary Communication, Male, Medication Adherence/statistics & numerical data, Neoplasms/drug therapy, Outpatients/statistics & numerical data, Patient-Centered Care/statistics & numerical data, Pharmacists, Physician's Role, Pilot Projects, Piperazines/administration & dosage, Prospective Studies, Pyrimidines/administration & dosage, Switzerland/epidemiology, Time Factors, Treatment Outcome
Pubmed
Create date
06/09/2011 10:40
Last modification date
20/08/2019 12:27
Usage data